Potential role of brain-derived neurotrophic factor in omega-3 fatty acid supplementation to prevent posttraumatic distress after accidental injury: An open-label pilot study

Psychotherapy and Psychosomatics

Volumn 80, Issue 5, 2011, Pages 310-312

  Matsuoka, Yutaka ^a,b,c   Nishi, Daisuke ^a,b,c   Yonemoto, Naohiro ^b,c   Hamazaki, Kei ^c,d   Hamazaki, Tomohito ^c,e   Hashimoto, Kenji ^c,f  

^a National Disaster Medical Center   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d Tottori University   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

^f CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID;

ACCIDENTAL INJURY; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; LETTER; OPEN STUDY; OUTCOME ASSESSMENT; PILOT STUDY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TREATMENT DURATION;

BRAIN-DERIVED NEUROTROPHIC FACTOR; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; STRESS DISORDERS, POST-TRAUMATIC; WOUNDS AND INJURIES;

EID: 79959637682     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000322980     Document Type: Letter

References (19)

1. Edwards R, Peet M, Shay J, Horrobin D: Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998; 48: 149-155. (Pubitemid 28244216)
2. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M: Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54: 70-75. (Pubitemid 36776725)
3. Kawakita E, Hashimoto M, Shido O: Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 2006; 139: 991-997.
4. Wu A, Ying Z, Gomez-Pinilla F: Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008; 155: 751-759.
5. Wu A, Ying Z, Gomez-Pinilla F: Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 2004; 21: 1457-1467. (Pubitemid 39435321)
6. Huang EJ, Reichardt LF: Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736. (Pubitemid 32695243)
7. Schinder AF, Poo M: The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci 2000; 23: 639-645. (Pubitemid 32007891)
8. Hashimoto K, Shimizu E, Iyo M: Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004; 45: 104-114. (Pubitemid 38625738)
9. Kitamura T, Saitoh Y, Takashima N, Murayama A, Niibori Y, Ageta H, Sekiguchi M, Sugiyama H, Inokuchi K: Adult neurogenesis modulates the hippocampus-dependent period of associative fear memory. Cell 2009; 139: 814-827.
10. Matsuoka Y, Nishi D, Yonemoto N, Hamazaki K, Hashimoto K, Hamazaki T: Omega-3 fatty acids for secondary prevention of posttraumatic stress disorder after accidental injury: an open-label pilot study. J Clin Psychopharmacol 2010; 30: 217-219.
11. Baker SP, O'Neill B: The injury severity score: an update. J Trauma 1976; 16: 882-885. (Pubitemid 8007770)
12. Teasdale G, Jennett B: Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;ii:81-84.
13. Nishi D, Matsuoka Y, Noguchi H, Sakuma K, Yonemoto N, Yanagita T, Homma M, Kanba S, Kim Y: Reliability and validity of the Japanese version of the Peritraumatic Distress Inventory. Gen Hosp Psychiatry 2009; 31: 75-79.
14. Asukai N, Hirohata S, Kato H, Konishi T: Psychometric properties of the Japanese-language version of the clinician-administered PTSD scale for DSM-IV (in Japanese). Jpn J Trauma Stress 2003; 1: 47-53.
15. Otsubo T, Tanaka K, Koda R, Shinoda J, Sano N, Tanaka S, Aoyama H, Mimura M, Kamijima K: Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview. Psychiatry Clin Neurosci 2005; 59: 517-526. (Pubitemid 41765747)
16. Matsuoka Y, Nishi D, Nakajima S, Yonemoto N, Hashimoto K, Noguchi H, Homma M, Otomo Y, Kim Y: The Tachikawa cohort of motor vehicle accident study investigating psychological distress: design, methods and cohort profiles. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 333-340.
17. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50: 260-265. (Pubitemid 32778442)
18. Venna VR, Deplanque D, Allet C, Belarbi K, Hamdane M, Bordet R: PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 2009; 34: 199-211.
19. Conklin SM, Gianaros PJ, Brown SM, Yao JK, Hariri AR, Manuck SB, Muldoon MF: Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Lett 2007; 421: 209-212. (Pubitemid 46935357)